335 related articles for article (PubMed ID: 27500670)
21. Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women.
Pyra M; Lingappa JR; Heffron R; Erikson DW; Blue SW; Patel RC; Nanda K; Rees H; Mugo NR; Davis NL; Kourtis AP; Baeten JM;
Contraception; 2018 Apr; 97(4):357-362. PubMed ID: 29408422
[TBL] [Abstract][Full Text] [Related]
22. Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review.
Callahan R; Yacobson I; Halpern V; Nanda K
Contraception; 2015 Dec; 92(6):514-22. PubMed ID: 26363431
[TBL] [Abstract][Full Text] [Related]
23. Hormonal Contraceptives and the Acquisition of Sexually Transmitted Infections: An Updated Systematic Review.
McCarthy KJ; Gollub EL; Ralph L; van de Wijgert J; Jones HE
Sex Transm Dis; 2019 May; 46(5):290-296. PubMed ID: 30628946
[TBL] [Abstract][Full Text] [Related]
24. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
Bosinger SE; Tharp GK; Patel NB; Zhao C; Payne TL; Dietz Ostergaard S; Butler K; Ellis S; Johnson RL; Kersh EN; McNicholl JM; Vishwanathan SA
Am J Reprod Immunol; 2018 Oct; 80(4):e13029. PubMed ID: 30076667
[TBL] [Abstract][Full Text] [Related]
25. Risk of HIV Infection in Depot-Medroxyprogesterone Acetate (DMPA) Users: A Systematic Review and Meta-analysis.
Brind J; Condly SJ; Mosher SW; Morse AR; Kimball J
Issues Law Med; 2015; 30(2):129-39. PubMed ID: 26710371
[TBL] [Abstract][Full Text] [Related]
26. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
Zalenskaya IA; Chandra N; Yousefieh N; Fang X; Adedipe OE; Jackson SS; Anderson SM; Mauck CK; Schwartz JL; Thurman AR; Doncel GF
J Clin Invest; 2018 Oct; 128(10):4622-4638. PubMed ID: 30222141
[TBL] [Abstract][Full Text] [Related]
27. Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
Chinula L; Nelson JAE; Wiener J; Tang JH; Hurst S; Tegha G; Msika A; Ellington S; Hosseinipour MC; Mataya R; Haddad LB; Kourtis AP
Contraception; 2018 Sep; 98(3):193-198. PubMed ID: 29746813
[TBL] [Abstract][Full Text] [Related]
28. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
[TBL] [Abstract][Full Text] [Related]
29. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.
Tepper NK; Krashin JW; Curtis KM; Cox S; Whiteman MK
MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):990-994. PubMed ID: 28934178
[TBL] [Abstract][Full Text] [Related]
30. Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches.
Polis CB; Westreich D; Balkus JE; Heffron R;
AIDS; 2013 Oct; 27 Suppl 1(0 1):S35-43. PubMed ID: 24088682
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.
Heffron R; Achilles SL; Dorflinger LJ; Hapgood JP; Kiarie J; Polis CB; Steyn PS
Contraception; 2019 Apr; 99(4):199-204. PubMed ID: 30576636
[TBL] [Abstract][Full Text] [Related]
32. Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial.
Singata-Madliki M; Lawrie TA; Balakrishna Y; d'Hellencourt FC; Hofmeyr GJ
Reprod Health; 2021 Sep; 18(1):192. PubMed ID: 34587971
[TBL] [Abstract][Full Text] [Related]
33. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.
Balkus JE; Brown ER; Hillier SL; Coletti A; Ramjee G; Mgodi N; Makanani B; Reid C; Martinson F; Soto-Torres L; Abdool Karim SS; Chirenje ZM
Contraception; 2016 Jan; 93(1):25-31. PubMed ID: 26519646
[TBL] [Abstract][Full Text] [Related]
34. New contraceptives in the 1990s.
O'Connell BJ
Curr Opin Pediatr; 1995 Aug; 7(4):371-5. PubMed ID: 7581638
[TBL] [Abstract][Full Text] [Related]
35. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
36. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(24):449-52. PubMed ID: 22717514
[TBL] [Abstract][Full Text] [Related]
37. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
Heffron R; Mugo N; Were E; Kiarie J; Bukusi EA; Mujugira A; Frenkel LM; Donnell D; Ronald A; Celum C; Baeten JM;
AIDS; 2014 Nov; 28(18):2771-6. PubMed ID: 25493602
[TBL] [Abstract][Full Text] [Related]
38. Combination injectable contraceptives for contraception.
Gallo MF; Grimes DA; Lopez LM; Schulz KF; d'Arcangues C
Cochrane Database Syst Rev; 2013; 3():CD004568. PubMed ID: 23641480
[TBL] [Abstract][Full Text] [Related]
39. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
Myer L; Denny L; Wright TC; Kuhn L
Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
[TBL] [Abstract][Full Text] [Related]
40. Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recommendations for the Use of Contraception Among Women at High Risk for HIV Infection.
Tepper NK; Curtis KM; Cox S; Whiteman MK
MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(14):405-410. PubMed ID: 32271729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
